High costs and technical limitations of cell sorting and single-cell techniques currently re-1 strict the collection of large-scale, cell-type-specific DNA methylation data for a large num-2 ber of individuals. This, in turn, impedes our ability to tackle key biological questions that 3 pertain to variation within a population, such as identification of disease-associated genes 4 at a cell-type-specific resolution. Here, we show mathematically and experimentally that 5 cell-type-specific methylation levels of an individual can be learned from its tissue-level bulk 6 data, as if the sample has been profiled with a single-cell resolution and then signals were 7 aggregated in each cell population separately. Thus, our proposed approach provides an 8 1 unprecedented way to perform powerful large-scale epigenetic studies with cell-type-specific 9 resolution using relatively easily obtainable large tissue-level data. We revisit previous stud-10 ies with methylation and reveal novel associations with leukocyte composition in blood and 11 multiple novel cell-type-specific associations with rheumatoid arthritis (RA). For the latter,
widely acceptable solution to this problem is to incorporate the cell-type composition information 78 into the analysis of the phenotype by introducing it as covariates in a regression analysis. This 79 approach results in an adjusted analysis which is conceptually similar to a study in which the cases 80 and controls are matched on cell-type distribution. Even though this procedure is useful in order 81 to eliminate spurious findings, it does not leverage the cell-type-specific signal, and thus results in 82 a sever power loss as explained below.
83
Given no statistical relation between the phenotype and the cell-type composition, associa-84 tion studies typically assume a model with the following structure:
Here, y represents the phenotype, x and β represent the bulk methylation level at a particular with the phenotype. Thus, a more realistic formulation would be:
Here, x 1 , ..., x k are the methylation levels in each of the k cell types composing the studied tissue
92
and β 1 , ..., β k are their corresponding cell-type-specific effects. and adjusted observed levels were calculated for each sample by removing the cell-type-specific mean levels, weighted by its cell-type composition.
from a distribution. We summarize and illustrate the model in Figure 2 . Based on this model,
106
we developed Tensor Composition Analysis (TCA), a method for learning the unique cell-type-107 specific methylomes for each individual sample from its bulk data. TCA requires knowledge of 108 the cell-type composition of the individuals in the data. In cases where the cell-type composition 109 is unknown, it can be computationally estimated using standard methods [23] [24] [25] [26] [27] . As we later show,
110
TCA performs well even in cases where only noisy estimates of the cell-type composition are 111 available.
112
Applying TCA for detecting cell-type-specific associations in epigenetic studies Figure S3 and ??).
119
We next evaluated the performance of TCA in detecting cell-type-specific associations by 120 simulating bulk methylation and corresponding phenotypes with cell-type-specific effects. Our Step 1: methylation altering covariates (e.g., age and sex) of a particular individual i can affect the methylation distribution of individual i.
Step 2: the cell-type-specific methylomes of individual i are generated for each of the k cell types in the studied tissue.
Step 3: the cell-type-specific methylomes of individual i (3.1) are combined according to the celltype composition of the individual (3.2).
Step 4: the true signal of the heterogeneous mixture (4.1) is distorted due to additional variation introduced by different sources of noise such as batch effects and other experiment-specific artificial variability (4.2); this results in the observed data.
Methylation levels are represented by a gradient of red color ( Figure 3 ). Remarkably, TCA improved the most upon the power of the standard approach in els in a particular cell type are not expected to be related to the tissue cell-type composition. Figure 4d and Supplementary File 2).
172
The presumption that only some particular immune cell-types are related to the pathogen- Note).
265
The model Let Z i
hj denote the value coming from cell type h ∈ 1, ..., k at methylation site 266 j ∈ 1, ...m in sample i ∈ 1, ...n, we assume:
In theory, the methylation status of a given site within a particular cell is a binary condition. for site j of sample i in the observed heterogeneous methylation data matrix X:
where w hi is the proportion of the h-th cell type of sample i in W , and ij represents an additional 282 component of measurement noise which is independent across all samples. We therefore get that
283
X ij follows a normal distribution with parameters that are unique for each individual i and site j.
284
Put differently, we assume that the entries of X are independent but also different in their means 285 and variances. 
where
Essentially, our suggested method, TCA, leverages the information given by the observed hj }. This is done by setting the estimatorẑ i j to be the mode of the conditional distribution in (5):
TCA requires the cell-type proportions W as an input. Given W , the parameters τ, {µ j }, {σ j }
293
can be estimated from the observed data under the assumption in (4). In practice, the cell-type pro- 
where Y i is the phenotypic level of individual i, β j is the effect size of the j-th site, and e i is a we look for all features j for which we have a sufficient statistical evidence of non-zero effect size 319 (i.e. β j = 0).
320
In principle, one can use TCA for estimating cell-type-specific levels, and then look for cell-321 type-specific associations by fitting the model in (11) with the estimated cell-type-specific levels
322
(instead of directly using X). However, an alternative one-step approach can be also used. This 323 approach leverages the information we gain about z i hj given that X ij = x ij for directly modeling 324 the phenotype as having cell-type-specific effects. Specifically, consider the following model:
where β lj denotes the cell-type-specific effect size of some cell type of interest l. Provided with the observed information x ij , while keeping the assumptions in (3) and in (4), it can be shown (Supplementary Note) that: we further excluded a small batch consisted of only 4 individuals. Finally, for the association ex-
401
periments with methylation, we further discarded consistently methylated probes and consistently 402 unmethylated probes from the data (mean value higher than 0.9 or lower than 0.1, respectively).
403
Power simulations We simulated data and sampled for each site under test a normally distributed 404 phenotype with additional effects of the cell-type-specific methylation levels of the site. We set when simulating effects coming from all cell types, we randomly generated a phenotype from a 411 normal distribution with the variance set to the total variance of the site under test (i.e. across all 412 cell types).
413
We performed the power evaluation using simulated data with 3 constituting cell types (k=3)
414
and using simulated data with 6 constituting cell types (k=6). We considered three scenarios across 415 a range of effect sizes as follows: different effect sizes for different cell types (using s joint test), the same effect size for all cell types (using a joint test, under the assumption of the same effect 417 for all cell types), and a scenario with only a single associated cell type (a marginal test CpGs separately) using clusterProfiler 49 . In order to find the genes whose expression can be well 501 explained by the 3 CD14+ specific associations that were reported by TCA and were found to 502 be enriched for correlation with RA pathway genes (cg13081526, cg13778567 and cg18816397),
503
we fitted a linear model for the log-transformed expression levels of each gene in the CD14+ 504 expression data using the 3 CpGs and the pairwise interactions between these 3 CpGs. The results
505
with the Reynolds are summarized in Supplementary File 3.
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